Back to Search
Start Over
Clinical characteristics of COVID-19 with cardiac injury: a systematic review and meta-analysis
- Source :
- Epidemiology and Infection
- Publication Year :
- 2020
- Publisher :
- Cambridge University Press (CUP), 2020.
-
Abstract
- Objectives Cardiac injury is associated with poor prognosis of 2019 novel coronavirus disease 2019 (COVID-19), but the risk factors for cardiac injury have not been fully studied. In this study, we carried out a systematic analysis of clinical characteristics in COVID-19 patients to determine potential risk factors for cardiac injury complicated COVID-19 virus infection. Methods We systematically searched relevant literature published in Pubmed, Embase, Europe PMC, CNKI and other databases. All statistical analyses were performed using STATA 16.0. Results We analysed 5726 confirmed cases from 17 studies. The results indicated that compared with non-cardiac-injured patients, patients with cardiac injury are older, with a greater proportion of male patients, with higher possibilities of existing comorbidities, with higher risks of clinical complications, need for mechanical ventilation, ICU transfer and mortality. Moreover, C-reactive protein, procalcitonin, D-dimer, NT-proBNP and blood creatinine in patients with cardiac injury are also higher while lymphocyte counts and platelet counts decreased. However, we fortuitously found that patients with cardiac injury did not present higher clinical specificity for chest distress (P = 0.304), chest pain (P = 0.334), palpitations (P = 0.793) and smoking (P = 0.234). Similarly, the risk of concomitant arrhythmia (P = 0.103) did not increase observably either. Conclusion Age, male gender and comorbidities are risk factors for cardiac injury complicated COVID-19 infection. Such patients are susceptible to complications and usually have abnormal results of laboratory tests, leading to poor outcomes. Contrary to common cardiac diseases, cardiac injury complicated COVID-19 infection did not significantly induce chest distress, chest pain, palpitations or arrhythmias. Our study indicates that early prevention should be applied to COVID-19 patients with cardiac injury to reduce adverse outcomes.
- Subjects :
- medicine.medical_specialty
Heart Diseases
Epidemiology
Pneumonia, Viral
coronavirus
Comorbidity
Review
030204 cardiovascular system & hematology
Chest pain
Procalcitonin
03 medical and health sciences
Betacoronavirus
0302 clinical medicine
Sex Factors
Risk Factors
Internal medicine
medicine
Palpitations
Humans
030212 general & internal medicine
Pandemics
business.industry
SARS-CoV-2
Acute kidney injury
Age Factors
COVID-19
medicine.disease
Angiotensin II
Cardiac injury
Infectious Diseases
Relative risk
Meta-analysis
medicine.symptom
business
Coronavirus Infections
meta analysis
Subjects
Details
- Language :
- English
- ISSN :
- 14694409 and 09502688
- Database :
- OpenAIRE
- Journal :
- Epidemiology and Infection
- Accession number :
- edsair.doi.dedup.....153c03dbd4269da014f79082d1527e05
- Full Text :
- https://doi.org/10.1017/s0950268820002587